Related Experiment Video
Updated: Feb 16, 2026

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain
Published on: April 9, 2019
Blood-brain barrier development: Systems modeling and predictive toxicology.
Katerine S Saili1, Todd J Zurlinden1, Andrew J Schwab2
1National Center for Computational Toxicology (NCCT); U.S. Environmental Protection Agency, Office of Research and Development, Research Triangle Park, North Carolina 27711.
This review explores blood-brain barrier (BBB) development and disruption, focusing on modeling its complex systems. Integrating computational and experimental models is crucial for assessing neurodevelopmental risks from chemical exposures.
Area of Science:
- Neuroscience
- Toxicology
- Pharmacology
Background:
- The blood-brain barrier (BBB) regulates substance exchange between blood and brain, crucial for neural function.
- BBB development and integrity are vital for normal brain development, and disruption can have significant impacts.
- The neurovascular unit (NVU) comprises cells and vessels critical for BBB function.
Purpose of the Study:
- To review BBB development, NVU microphysiology, and the effects of BBB disruption on brain development.
- To highlight the current state and future needs of in silico and in vitro models for studying the BBB.
- To emphasize the importance of integrated modeling approaches for neurodevelopmental risk assessment.
Main Methods:
- Review of existing literature on BBB development, NVU function, and modeling approaches.
- Discussion of in silico models for predicting drug/chemical passage across the BBB.
- Examination of in vitro platforms (high-throughput screening, microphysiological systems) for profiling interactions and investigating NVU dynamics.
Main Results:
- Current in silico models predict BBB passage, while in vitro platforms offer data on chemical-biological interactions.
- Engineered human cell-based microphysiological systems provide empirical models for NVU function dynamics.
- There is a need for computational models integrating kinetic and dynamic NVU functions across gestation and different scenarios.
Conclusions:
- Integrated computational and experimental models are essential for understanding BBB dynamics and neurodevelopmental impacts.
- Improved modeling will reduce uncertainty in translating in vitro and in silico data for risk assessment.
- These advancements are critical for protecting neurodevelopmental health from chemical exposures.
Related Concept Videos
The Blood-brain Barrier
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

